Renata to Raise Tk 325 Crore via Preference Share Issue
Renata PLC, a pharmaceutical and chemical sector company listed on the stock exchange, has decided to issue preference shares to…
Renata Introduces Parkinson’s and Hyperprolactinemia Drug in Australia
Renata PLC, a leading pharmaceutical manufacturer in Bangladesh, has launched a generic version of Cabergoline 0.5 mg, used to treat…
Renata Reports 55% Profit Increase
Renata PLC reported significant growth in fiscal year 2023-24, with revenue increasing 14% year-on-year to Tk 3,771 crore and profit…
Renata Gets EU Approval for Cabergoline 0.5 mg Tablet
Renata PLC, a publicly traded pharmaceutical company, has received European approval to market Cabergoline 0.5 mg tablets for treating hyperprolactinemia…
IFC to Provide $60 Million Loan to Renata
Renata PLC, a leading pharmaceutical company in Bangladesh, plans to secure a $60 million loan from the International Finance Corporation…